First-in-class, protein-protein interaction inhibitors against invasive cancers.
Location: Switzerland, Zurich
Member count: 1-10
Total raised: $4.608799M
Investors 5
| Date | Name | Website |
| 16.06.2022 | OCCIDENT | occident.g... |
| - | Verve Vent... | verve.vc |
| - | Venture Ki... | venturekic... |
| - | VentureLab | venturelab... |
| 08.06.2022 | High-Tech ... | htgf.de |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 07.06.2022 | Seed | $4.608799M | - | htgf.de/en... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 07.06.2022 | Invasight ... | June 7, 2022 The funds will a... | - | - | htgf.de/en... |
| 07.06.2022 | Invasight ... | Leveraging their ACINDA plat... | Financing | - | startuptic... |